Atmofizer's Financial Pivot: Fueling a Coca Leaf Innovator's Public Debut

VANCOUVER, BC – July 22, 2026 – At first glance, the latest press release from Atmofizer Technologies Inc. reads like a standard piece of corporate housekeeping. The company announced the closing of C$160,000 in convertible debenture financing and the settlement of C$440,000 in debt through an issuance of shares. For those not versed in the language of corporate finance, such announcements are easily dismissed as arcane background noise. But to do so would be to miss the real story: this isn't just about balancing the books; it's about building a launchpad for a completely new enterprise.

These financial maneuvers are the critical fuel for a proposed reverse takeover (RTO) that will see Atmofizer, once a developer of clean air technology, merge with Power Leaves Corp. (PLC), an ambitious company aiming to revolutionize the food and beverage industry with decocainized coca leaf extract. In essence, Atmofizer is meticulously clearing its own financial runway while refueling its incoming partner, orchestrating a strategic transformation that speaks volumes about the creative and often complex paths to growth in today's capital markets.

The Mechanics of a Strategic Pivot

The strategic calculus here is clear and demonstrates a classic RTO playbook. Atmofizer, a publicly listed entity on the Canadian Securities Exchange (CSE: ATMO), is leveraging its existing public status to provide a faster, more efficient route to the market for a private company. The C$160,000 raised via convertible debentures is not for Atmofizer's own operations. As the company stated, these funds will be advanced directly to Power Leaves Corp. as an unsecured bridge loan.

This bridge loan is a lifeline, designed to cover PLC’s working capital, transaction expenses, and general corporate needs in the crucial period leading up to the RTO's closing. It ensures the target company remains healthy and focused on the transaction without the distraction of a cash crunch. The 'convertible' nature of the debentures is also key; it gives Atmofizer the option to settle this debt not with precious cash, but with shares in the new, combined entity. It’s a capital-efficient way to fund a partner's pre-merger needs.

Simultaneously, Atmofizer is cleaning its own house. The company settled C$440,000 of its outstanding debt by issuing 8.8 million common shares at a deemed price of C$0.05 per share. This shares-for-debt settlement is a powerful tool. It removes a significant liability from Atmofizer’s balance sheet without a cash outlay, making it a much 'cleaner' and more attractive shell for the RTO. A company burdened by debt is a far less appealing partner. By converting that debt to equity, Atmofizer presents a tidier financial profile, smoothing the path for regulatory and shareholder approvals.

Meet the New Engine: Power Leaves Corp.

While Atmofizer is the vehicle, Power Leaves Corp. is the engine driving this transaction. Founded in 2019, PLC is not just another beverage ingredient startup; it is pioneering a category that has been dormant and misunderstood for decades. The company has established what it claims is the first legal supply chain in Colombia for decocainized coca leaf extract, working in an exclusive partnership with an Indigenous community.

For centuries, the coca leaf has been inextricably linked with cocaine. However, Power Leaves is focused on the leaf's properties after the cocaine alkaloid has been removed. The resulting extract is rich in protein and nutrients and offers a unique taste profile. The company is developing proprietary formulations, including a plant-based extract called "DeCarb," designed to reduce sugar content and the bitterness of caffeine in beverages. The vision is to position this extract as a natural, healthy, and sustainable ingredient for the global food and beverage markets.

The strategic importance of this venture cannot be overstated. Power Leaves aims to become the first publicly traded manufacturer and distributor of decocainized-coca derivatives in the world, disrupting a market that has been tightly controlled under UN regulations. According to company materials, they have already secured commercial agreements and letters of intent with flavor houses, suggesting that market demand for their innovative ingredient is real. For PLC, the RTO with Atmofizer is not merely a financial transaction; it is the key to unlocking the public capital needed to scale production, implement quality systems, and execute a global commercial strategy.

A Calculated Risk with High Stakes

This corporate transformation is not without its risks, a fact reflected in Atmofizer's market valuation. The company's stock has been trading at penny-stock levels, a common scenario for shell companies awaiting a transformative transaction. The success of this RTO hinges on numerous factors, including the receipt of all necessary regulatory and shareholder approvals and the successful completion of PLC's concurrent financing efforts to raise up to US$4.0 million.

The forward-looking statements in the company's own press release serve as a necessary caution, noting that "general business, economic, competitive, political and social uncertainties" could impact the outcome. The journey from a definitive agreement, signed in April 2026, to a final closing is fraught with potential delays and hurdles.

However, for investors and market watchers, this is a story about strategic reinvention. Atmofizer is transitioning from an operating company in the clean-tech space to a strategic financial vehicle. Its management is betting that the future value for its shareholders lies not in its own past operations, but in facilitating the growth of a disruptive new business. Upon completion, the resulting entity will be renamed "Power Leaves Holdings Corp." and will trade on the CSE, carrying the ambitions of a company poised to introduce a novel ingredient to the world. The market's true verdict will arrive when the new entity begins trading and must prove it can execute on its bold and unconventional business plan.